Elyxium Wealth’s ADMA Biologics ADMA Stock Holding History

Elyxium Wealth’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.16K	Buy	+415	New	+$3.84K	﹤0.01%	1203

Other funds holding ADMA

Marathon Capital Management Hunt Valley, Maryland $488M AUM 28.5% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Motley Fool Asset Management Alexandria, Virginia $2.64B AUM 26.58% 1-Year Est. Return

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

Empirical Wealth Management Seattle, Washington $7.38B AUM 22.9% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return

Elyxium Wealth's ADMA Position: Q3 2026 in Review

Elyxium Wealth opened a new position in ADMA Biologics (ADMA) in Q3 2026: 415 shares worth $4.16K. The stake represents ﹤0.01% of the portfolio and ranks #1203 among its holdings.

78 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

Elyxium Wealth held 415 shares of ADMA Biologics worth $4.16K as of Q3 2026.
ADMA Biologics was a new Elyxium Wealth position in Q3 2026.
ADMA Biologics made up ﹤0.01% of Elyxium Wealth's portfolio in Q3 2026, its #1203 holding.
78 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on Elyxium Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.